GLP-1 Weight Loss
MEDVi GLP-1 Review: 500,000 Patients, $179 to Start, Brand and Compounded in One Program
Best for Established Telehealth Brand
At a Glance
- Best for
- Women who want a large, established GLP-1 telehealth brand with multiple medication formats and bundled care
- Starting price
- $179/mo
- Editor score
- 9.1/10
Overview
MEDVi is one of the largest dedicated telehealth GLP-1 weight loss brands in the United States. The company reports over 500,000 patients treated, and unlike most compounded-only competitors, MEDVi runs a full multi-format program: a $179/mo compounded GLP-1 injection, a $249/mo dissolvable GLP-1 tablet, and brand-name Wegovy and Zepbound through a $99/mo membership. That breadth is what sets MEDVi apart in our 2026 review.
For readers who want a serious, established GLP-1 program and are willing to pay slightly more than the cheapest compounded option in exchange for scale, format flexibility, and bundled support, MEDVi is the program we would point them to.
At a Glance
| Pricing | From $179/mo (GLP-1 injection), $249/mo (tablet), $99/mo membership for brand-name |
| Medications | Compounded Semaglutide injection, dissolvable GLP-1 tablet, Wegovy pill, Wegovy injection, Zepbound injection |
| Provider | Licensed clinicians, fully online |
| Delivery | Free shipping on the $179 plan |
| Bundled care | Free dietitian visits and care coaching included |
| Payment | HSA and FSA approved |
How It Works
- Online evaluation. You complete a quick online intake. MEDVi’s clinical team reviews your weight history, medical history, and goals to decide whether GLP-1 medication is appropriate for you.
- Personalized prescription. If you are approved, a licensed clinician issues a prescription matched to your goals and health profile. You can choose between the injection, the dissolvable tablet, or a brand-name option.
- Shipped to your door. Your medication ships directly from one of MEDVi’s partner pharmacies, with free shipping on the core $179 injection plan. Care coaching and dietitian visits start as soon as you are enrolled.
The intake-to-medication flow is similar to other telehealth GLP-1 programs, but the bundled dietitian and care coaching is something most of MEDVi’s competitors do not include.
Pricing Breakdown
| Plan | Price | What you get |
|---|---|---|
| GLP-1 Injection | $179/mo | Compounded Semaglutide weekly injection, provider review, free shipping |
| GLP-1 Tablet | $249/mo | Dissolvable GLP-1 tablet, daily, provider review |
| Wegovy Pill | $99/mo membership + medication cost | Brand-name oral GLP-1 |
| Wegovy Injection | $99/mo membership + medication cost | Brand-name weekly injection (availability subject to change) |
| Zepbound Injection | $99/mo membership + medication cost | Brand-name Tirzepatide injection (availability subject to change) |
The $179 entry price is higher than the cheapest compounded options on the market. What you get for the difference is the scale of an established brand, free dietitian visits, care coaching, and a clearly published path to brand-name medication if compounded options ever become unavailable. That last point matters: if the FDA shortage status of GLP-1 medications shifts and compounded supply tightens, a program with brand-name access already built in is more durable.
The Hormone Science
GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone released by the gut after meals. It signals satiety to the brain, slows gastric emptying, and helps regulate blood sugar. GLP-1 medications mimic that signal at a steadier level than your body produces on its own. Most patients report reduced appetite, fewer cravings, and a quieter version of the constant food noise that drives weight regain. MEDVi’s positioning leans into the metabolic science directly: the program treats weight as a metabolic and hormonal issue, and reports an average 18% body weight loss across its first six months of treatment.
Pros
- One of the largest telehealth GLP-1 brands, with over 500,000 patients treated
- Multiple medication formats under one program, including brand-name Wegovy and Zepbound
- Free dietitian visits and care coaching included with the core plan
- HSA and FSA approved, which can meaningfully reduce the effective cost
- No membership fee on the $179 injection plan, free shipping included
Cons
- $179 is a higher starting price than the cheapest compounded competitors
- Brand-name medications require a $99 monthly membership on top of medication cost
- Compounded medications are not FDA-approved (a category-wide limitation)
Who It’s For
MEDVi is the right fit for women who want the security of a large, established GLP-1 telehealth brand and value bundled care. If you want dietitian and care coaching included, or if you specifically want a program that already has brand-name medication access built in, MEDVi is a strong choice. The HSA and FSA acceptance can also make the effective cost meaningfully lower for readers who have either kind of account.
Who Should Skip
If your only filter is the lowest possible monthly price for compounded Semaglutide, MEDVi is not the cheapest option in our 2026 review. The $50/mo gap between MEDVi and the lowest-priced compounded program is real, and for some readers that math will outweigh the benefits of MEDVi’s scale and bundled care. MEDVi is also not the right fit if you are looking for a smaller, more boutique provider experience.
Side Effects and Safety
Common GLP-1 side effects include mild nausea, occasional reflux, and slower digestion in the first few weeks. Most patients adjust as their body adapts to the medication, and dose escalation can be slowed if needed. MEDVi’s care coaching includes guidance on managing these early effects, which is a meaningful part of why the program reports strong long-term adherence.
GLP-1 medications are not appropriate for everyone. People with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not take GLP-1 receptor agonists. People with a history of pancreatitis, severe GI motility disease, or active gallbladder disease should consult their primary care physician before starting. MEDVi’s intake screens for these, but readers should still surface their full medical history during the assessment.
Bottom Line
MEDVi is the program we would recommend to a reader who wants a large, well-supported GLP-1 telehealth brand and is willing to pay $179/mo instead of the cheapest possible compounded option. The bundled dietitian visits, care coaching, HSA/FSA acceptance, and brand-name medication access are real differentiators, and the 500,000-patient track record gives MEDVi a credibility advantage that smaller programs simply cannot match.
For readers whose top priority is the absolute lowest price, the cheapest compounded option will be a better fit. For everyone else who wants serious GLP-1 treatment from an established brand with a complete care package, MEDVi is the program that does the most across the most variables, and that is why it is our 2026 runner-up pick.
Final Score Breakdown
| Category | Score |
|---|---|
| Affordability | 8.5 |
| Provider Quality | 9.3 |
| User Experience | 9.2 |
| Customer Support | 9.4 |
| Overall | 9.1 |
Try MEDVi
If you want to see whether MEDVi is a fit, the next step is the online medical assessment. It takes a few minutes and a licensed provider reviews your answers before any medication is prescribed.
Start your MEDVi assessment
Free shipping is included on the $179 GLP-1 injection plan. HSA and FSA accepted.